PRMT5/MEP50, FLAG-Tag, His-Tag (Sf9-derived) Recombinant

Catalog #
51048
$515 *
Size: 20 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Complex of human recombinant PRMT and MEP50 proteins. Recombinant human PRMT5 (protein arginine methyltransferase 5, variant 1), encompassing amino acids 2-637(end). This construct contains an N-terminal Flag-tag. Recombinant human MEP50 (WD repeat domain 77, variant 2), encompassing amino acids 2-342(end). This construct contains an N-terminal His-tag (6xHis). The two proteins were co-expressed and affinity purified.

This product has been cited 1 time.

Synonyms
PRMT5, HRMT1L5, IBP72, JBP1, SKB1, PRMT-5
Product Info
Storage and Usage
Citations1
Species
Human
Construct
PRMT5 (FLAG-2-637(end))/MEP50 (His-2-342(end))
Host Species/Expression System
Sf9
Purity

≥90%

Format
Aqueous buffer solution
Formulation

40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, variable FLAG peptide, and 20% glycerol.

MW
PRMT5: 73 kDa; MEP50: 38 kDa
Amino Acids
PRMT5: 2-637(end); MEP50: 2-342(end)
Genbank #
PRMT5: NM_006109; MEP50: NM_024102
UniProt #
PRMT5: O14744; MEP50: Q9BQA1
Tag(s)
PRMT5: N-terminal FLAG-tag; MEP50: N-terminal His-tag
Background

Three types of arginine methylation exist in mammalian cells: monomethylarginine (MMA), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Type I PRMTs ((CARM1, PRMT1, PRMT2, PRMT3, PRMT6, and PRMT8) catalyze ADMA, while type II PRMTs (e.g. PRMTs 5 and 7) catalyze SDMA. Type II PRMTs are found to be strongly implicated in diseases like cancer. For example, PRMT5 plays a role in the repression of certain tumor suppressor genes such as RB tumor suppressors while PRMT7 overexpression is observed in breast cancer